
Natera NTRA
$ 216.5
-2.84%
Quarterly report 2026-Q1
added 05-30-2026
Natera P/B Ratio 2011-2026 | NTRA
Annual P/B Ratio Natera
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8 | 23.3 | 33.6 | 7.52 | 12.9 | 16.6 | 8.84 | 26.3 | -54.4 | 4.2 | 1.21 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.6 | -54.4 | 8.89 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 203.78 | -0.37 % | $ 22.6 B | ||
|
Celcuity
CELC
|
53.4 | $ 88.24 | -4.7 % | $ 4.13 B | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 4.88 | 8.44 % | $ 6.49 M | ||
|
Fulgent Genetics
FLGT
|
0.476 | $ 18.93 | 2.32 % | $ 583 M | ||
|
Castle Biosciences
CSTL
|
1 | $ 21.08 | - | $ 611 M | ||
|
Aspira Women's Health
AWH
|
0.434 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.181 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
1.1 | $ 144.59 | -4.76 % | $ 11.3 B | ||
|
Illumina
ILMN
|
3.8 | $ 162.47 | 1.52 % | $ 25.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-135 | $ 130.7 | 0.45 % | $ 16.4 B | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 23.46 | 3.12 % | $ 1.25 B | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.0622 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
8.08 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.736 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 100.24 | 0.26 % | $ 6.77 B | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 186.29 | -1.88 % | $ 9.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
93.1 | $ 1.37 | - | $ 411 M | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 465.73 | -0.23 % | $ 13.4 B | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
-1.2 K | $ 1 133.03 | -2.58 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
1.77 | $ 11.28 | -1.4 % | $ 1.44 B | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 4.43 | -2.42 % | $ 410 M | ||
|
National Research Corporation
NRC
|
22.5 | $ 21.28 | 7.75 % | $ 476 M | ||
|
Personalis
PSNL
|
1.65 | $ 9.61 | -1.44 % | $ 858 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.76 | $ 25.67 | -3.13 % | $ 24.3 B | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 7.3 | -1.75 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
4.63 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
1.75 | $ 2.02 | -1.51 % | $ 4.64 M | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | $ 67.77 | -3.27 % | $ 4.05 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 268.63 | -0.96 % | $ 22.4 B | ||
|
Thermo Fisher Scientific
TMO
|
1.78 | $ 482.04 | -2.43 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
-5.51 | $ 0.69 | 3.51 % | $ 248 M | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 9.17 | -1.29 % | $ 1.99 B | ||
|
Invitae Corporation
NVTA
|
5.02 | - | - | $ 21.2 M |